Skip to main content

FTC investigating Johnson & Johnson's Remicade contracting practices

Pfizer sued Johnson & Johnson in 2017 alleging the company was engaged in anticompetitive tactics to slow sales of biosimilars.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.